3-(4-trifluoromethylphenyl)-4-isoxazolylmethanol | 430535-01-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(4-trifluoromethylphenyl)-4-isoxazolylmethanol
• 英文别名: [3-[4-(trifluoromethyl)phenyl]-1,2-oxazol-4-yl]methanol
• CAS: 430535-01-6
• 化学式: C₁₁H₈F₃NO₂
• 分子量: 243.185
• InChiKey: DYBSGRZVAKPFNY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  46.3
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  dihydroartemisinin 、 3-(4-trifluoromethylphenyl)-4-isoxazolylmethanol 在 三氟化硼乙醚 作用下， 以 氯仿 为溶剂， 反应 0.25h， 以37%的产率得到3-[4-(trifluoromethyl)phenyl]-4-[[(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl]oxymethyl]-1,2-oxazole
  参考文献：
  名称：

  Antimalarial activity of new ethers and thioethers of dihydroartemisinin

  摘要：

  Various ethers and thioethers of dihydroartemisinin were prepared by treating dihydroartemisinin with hydroxy alkyl, substituted phenol, hydroxy aralkyl, hydroxy alkynyl and hydroxy heteroalkyl or thiols in the presence of BF(3)Et(2)O. The thioethers 64 and 65 were further oxidised to the respective sulfoxides. These derivatives were tested in the Plasmodium berghei K-173-infected mice and some active compounds were tested in chloroquine-resistant P yoelii nigeriensis (NS)-infected mice. Initially the compounds were administered subcutaneously and subsequently by the oral route. The antimalarial activity of the compounds 22, 23, 36, 66 and 79 were found to be comparable to that of arteether when tested in the K-173-infected mice. These compounds also showed activity in the P y nigeriensis (NS)-infected mice.

  DOI：

  10.1016/0223-5234(96)88287-0
• 作为产物：
  描述：

  ethyl 3-(4-trifluoromethylphenyl)isoxazole-4-carboxylate 在 二异丁基氢化铝 作用下， 以 四氢呋喃 为溶剂， 以95%的产率得到3-(4-trifluoromethylphenyl)-4-isoxazolylmethanol
  参考文献：
  名称：

  EP1340749

  摘要：

  公开号：

文献信息

• Isoxazole derivatives
  申请人：——

  公开号：US20040048908A1

  公开（公告）日：2004-03-11

  A compound represented by the formula (I) 1 wherein one of R 1 and R 2 is a hydrogen atom or a substituent and the other is an optionally substituted cyclic group; W is a bond or a divalent aliphatic hydrocarbon group; Y is a group of the formula: —OR 3 (wherein R 3 is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group or an optionally substituted acyl group) or an optionally esterified or amidated carboxyl group, or a salt thereof or a prodrug thereof has a superior insulin secretion promoting action and a hypoglycemic action and shows low toxicity. Therefore, the compound is useful as a pharmaceutical agent, particularly as an agent for the prophylaxis or treatment of diabetes and diabetic complications, and the like.

  化合物的化学式为（I）1，其中R1和R2中的一个是氢原子或取代基，另一个是可选取代的环状基团；W是键或二价脂肪基碳氢基团；Y是式子：—OR3的基团（其中R3是氢原子、可选取代的碳氢基团、可选取代的杂环基团或可选取代的酰基基团），或可选酯化或酰胺化的羧基团，或其盐或前药。该化合物具有优异的促胰岛素分泌作用和降血糖作用，并且毒性低。因此，该化合物可用作制药剂，特别是用作糖尿病和糖尿病并发症的预防或治疗剂等。
• ISOXAZOLE DERIVATIVES
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1340749A1

  公开（公告）日：2003-09-03

  A compound represented by the formula (I) wherein one of R1 and R2 is a hydrogen atom or a substituent and the other is an optionally substituted cyclic group; W is a bond or a divalent aliphatic hydrocarbon group; Y is a group of the formula: -OR3 (wherein R3 is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group or an optionally substituted acyl group) or an optionally esterified or amidated carboxyl group, or a salt thereof or a prodrug thereof has a superior insulin secretion promoting action and a hypoglycemic action and shows low toxicity. Therefore, the compound is useful as a pharmaceutical agent, particularly as an agent for the prophylaxis or treatment of diabetes and diabetic complications, and the like.

  由式（I）代表的化合物 其中 R1 和 R2 中的一个是氢原子或取代基，另一个是任选取代的环状基团； W 是键或二价脂族烃基； Y 是式中的一个基团：-OR3（其中 R3 是氢原子、任选取代的烃基、任选取代的杂环基或任选取代的酰基）或任选酯化或酰胺化的羧基，或其盐或其原药具有优异的促进胰岛素分泌作用和降血糖作用，且毒性低。因此，该化合物可用作药物制剂，特别是用于预防或治疗糖尿病和糖尿病并发症等。
• US7022725B2
  申请人：——

  公开号：US7022725B2

  公开（公告）日：2006-04-04
• EP1340749
  申请人：——

  公开号：——

  公开（公告）日：——
• Antimalarial activity of new ethers and thioethers of dihydroartemisinin
  作者：B Venugopalan、PJ Karnik、CP Bapat、DK Chatterjee、N Iyer、D Lepcha

  DOI：10.1016/0223-5234(96)88287-0

  日期：1995.1

  Various ethers and thioethers of dihydroartemisinin were prepared by treating dihydroartemisinin with hydroxy alkyl, substituted phenol, hydroxy aralkyl, hydroxy alkynyl and hydroxy heteroalkyl or thiols in the presence of BF(3)Et(2)O. The thioethers 64 and 65 were further oxidised to the respective sulfoxides. These derivatives were tested in the Plasmodium berghei K-173-infected mice and some active compounds were tested in chloroquine-resistant P yoelii nigeriensis (NS)-infected mice. Initially the compounds were administered subcutaneously and subsequently by the oral route. The antimalarial activity of the compounds 22, 23, 36, 66 and 79 were found to be comparable to that of arteether when tested in the K-173-infected mice. These compounds also showed activity in the P y nigeriensis (NS)-infected mice.